Premium
Prevalence and severity of periodontal disease in patients with inflammatory bowel disease
Author(s) -
Flemmig Thomas F.,
Shanahan Fergus,
Miyasaki Kenneth T.
Publication year - 1991
Publication title -
journal of clinical periodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.456
H-Index - 151
eISSN - 1600-051X
pISSN - 0303-6979
DOI - 10.1111/j.1600-051x.1991.tb00111.x
Subject(s) - medicine , inflammatory bowel disease , ulcerative colitis , quadrant (abdomen) , disease , clinical attachment loss , gastroenterology , periodontal disease , gingival and periodontal pocket , dentistry , pathology
Previous reports have demonstrated that oral mucosa and periodontal lesions occur in patients suffering from inflammatory bowel disease (Crohn's disease [CD] and ulcerative colitis [UC]). It is unknown whether periodontal disease is an occasional or regular finding in these patients. The purpose of this study was to assess the prevalence and severity of periodontal disease in patients with inflammatory bowel disease (IBD). The periodontal status of 107 consecutive patients seeking treatment for inflammatory bowel disease was assessed. Examination of the mid‐ and mesiobuccal aspects of one quadrant on one jaw and the contralateral quadrant of the opposite jaw revealed that 93.5% of the CD patients and 95.1% of UC patients had at least one site with probing attachment loss of 2 mm or greater, and a mean probing attachment loss of 1.4 ± 0.9 mm and 1.5 ± 1.0 mm, respectively. We found that 28.3% of CD patients and 29.5% of UC patients possessed at least 1 site with a pocket probing depth of 4 mm or greater; the mean pocket probing depth in these patients was 2.4 ± 0.2 mm and 2.3 ± 0.2 mm, respectively. Compared with the assessment of Oral Health of United States Adults, IBD patients revealed a 11.9% higher prevalence (P0.01) but 0.6 mm lower severity (P0.01) of periodontal disease. The magnitudes of these differences suggest no clinical implications for the management of periodontal disease in IBD subjects.